Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Psychotic Disorders: early-phase trial registry
6 of 23 indexed Psychotic Disorders trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #724 of 28,707 conditions by registered trial count.
23 US clinical trials · 6 currently recruiting · #724 of 28,707 conditions by registered trial count
Psychotic Disorders: 23 US clinical trials tracked, 6 recruiting.
Psychotic Disorders is the subject of 23 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is VA Office of Research and Development, running 4 of these trials.
Enrollment posture brief
Registry condition psychotic-disorders
OPEN 6 | RECR 26% | LATE 2 | EARLY 6 | RANK #724 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Parkinson's Disease (26% recruiting · 161 trials)
Psychotic Disorders lists 6 open slots (26% of 23 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Psychotic Disorders on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Psychotic Disorders is recruiting below its size-band peers.
6 of 23 indexed trials (26.1%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Psychotic Disorders research.
VA Office of Research and Development accounts for 4 of 23 trials (17.4%). 16 distinct sponsors appear on at least one study for this condition label.
-
Typical Psychotic Disorders enrolment sits around 133 participants.
Median target enrolment is 133 among the 23 trials that report a genuine target (sentinel values excluded). 9 of those (39.1%) plan for fewer than 100 participants.
-
Psychotic Disorders research is mostly interventional.
21 interventional and 2 observational studies make up this index (91.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
23 total, page 1 of 1
Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders
Maastricht University Medical Center
NCT05656469
Racial Disparities in the Expression of Paranoia
Indiana University
NCT07460453
A Preventive Behavioral Intervention for Young Adults With Psychotic Experiences
Massachusetts General Hospital
NCT06929442
CBT-CP for Veterans With SMI
VA Office of Research and Development
NCT06758414
Development of a Transdiagnostic Intervention for Adolescents at Risk for Serious Mental Illness
Massachusetts General Hospital
NCT05962879
A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness
VA Office of Research and Development
NCT05537376
Family-Focused Therapy for Individuals at High Clinical Risk for Psychosis: A Confirmatory Efficacy Trial
University of California, Los Angeles
NCT04338152
Reconnecting to Ourselves and Others in Virtual Meetings (ROOM)
Massachusetts General Hospital
NCT06360562
Cannabinoids, Learning, and Memory
Yale University
NCT02407808
Early Detection and Intervention for the Prevention of Psychosis
MaineHealth
NCT00531518
Relative Bioavailability of LY03010 Compared to Listed Drug
Luye Pharma Group
NCT04922593
Longitudinal Multimodal Neuroimaging Studies in Patients With First Episode Psychosis
Mclean Hospital
NCT01688765
Antipsychotic Discontinuation in Alzheimer's Disease
New York State Psychiatric Institute
NCT00417482
Supported Employment: Motivational Enhancement for Entry and Outcome
VA Office of Research and Development
NCT01041976
Family-Focused Therapy for Youth With Early-Onset Bipolar or Psychotic Disorders
University of California, Los Angeles
NCT02097563
Reducing Weight Gain and Improving Metabolic Function in Children Being Treated With Antipsychotics
Johns Hopkins University
NCT00806234
Psychosis: Early Detection, Intervention and Prevention
MaineHealth
NCT01597141
Clinical and Biological Characteristics of Psychotic Depression
Stanford University
NCT00576095
Treating Smokers With Mental Illness
University of Minnesota
NCT03822416
A Concierge Model of CAE Plus LAI in Individuals With Schizophrenia at Risk for Treatment Non-adherence and Homelessness
University Hospitals Cleveland Medical Center
NCT02085447
Acceptance and Commitment Therapy for the Inpatient Treatment of Psychosis
VA Office of Research and Development
NCT01981356
Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)
Butler Hospital
NCT03769493
Antidepressant and Antipsychotic to Treat Attenuated Positive and Negative Symptoms
Northwell Health
NCT00169988
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Psychotic Disorders records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Psychotic Disorders trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Psychotic Disorders page
23 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Psychotic Disorders trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- VA Office of Research and Development sponsors the most Psychotic Disorders trials on record, review their full trial history before evaluating a specific study. See VA Office of Research and Development's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Psychotic Disorders condition card totals 23 registered trials; most-linked intervention risperidone; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.